Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advancing Eyecare is a leading provider of ophthalmic instruments and services, serving as a comprehensive solution for eye care professionals across North America. The company was formed through the strategic combination of several industry-leading brands, including Lombart Instrument, Marco Ophthalmic, and INNOVA Medical. Its product portfolio encompasses a wide range of diagnostic and surgical equipment, such as digital refraction systems, retinal imaging devices, and lane equipment. In addition to equipment distribution, the company provides extensive technical service, clinical training, and practice management solutions. Advancing Eyecare currently operates as a portfolio company of the private equity firm Cornell Capital, following its acquisition in 2022. The organization aims to improve practice efficiency and patient outcomes by offering integrated technology solutions and expert support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advancing Eyecare Holdings.